Chronic renal failure classification
Chronic renal failure Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Chronic renal failure classification On the Web |
American Roentgen Ray Society Images of Chronic renal failure classification |
Risk calculators and risk factors for Chronic renal failure classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
The purpose of CKD staging is to guide management, including stratification of risk for progression and complications of CKD. Risk stratification is used as a guide to inform appropriate treatments and the intensity of monitoring and patient education. In patients who are diagnosed with CKD using the criteria described above, staging of the CKD is done according to
Chronic kidney disease classification based upon glomerular filtration rate and albuminuria:
GFR stages | GFR(mL/min/1.73 m2) | Terms |
G1 | ≥90 | Normal or high |
G2 | 60 to 89 | Mildly decreased |
G3a | 45 to 59 | Mildly to moderately decreased |
G3b | 30 to 44 | Moderately to severely decreased |
G4 | 15 to 29 | Severely decreased |
G5 | <15 | Kidney failure (add D if treated by dialysis) |
Albuminuria stages | AER(mg/day) | Terms |
A1 | <30 | Normal to mildly increased (may be subdivided for risk prediction) |
A2 | 30 to 300 | Moderately increased |
A3 | >300 | Severely increased (may be subdivided into nephrotic and non-nephrotic for differential diagnosis, management, and risk prediction) |
- Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
- If the staging system involves specific and characteristic findings and features:
- According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
- The staging of [malignancy name] is based on the [staging system].
OR
- There is no established system for the staging of [malignancy name].